131 – 140 of 362
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
A prospective study to evaluate the intra-individual reproducibility of bone scans for quantitative assessment in patients with metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Social constraints and psychological well-being after prostate cancer : A follow-up at 12 and 24 months after surgery
(
- Contribution to journal › Article
-
Mark
Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial
(
- Contribution to journal › Article
-
Mark
Role of serum response factor expression in prostate cancer biochemical recurrence
(
- Contribution to journal › Article
-
Mark
A phase III study of INCB054828 as adjuvant therapy in patients (pts) with high-risk urothelial carcinoma (UC) harboring fibroblast growth factor receptor 3 (FGFR3) genomic alterations
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.328-328(
- Contribution to journal › Article
- 2017
-
Mark
Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting
(
- Contribution to journal › Article
-
Mark
Lower prostate cancer risk in Swedish men with the androgen receptor E213 A-allele
(
- Contribution to journal › Article
-
Mark
Automatic Gleason grading of H&E stained microscopic prostate images using deep convolutional neural networks
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Habits and self-assessed quality of life, negative intrusive thoughts and depressed mood in patients with prostate cancer : a longitudinal study
(
- Contribution to journal › Article
-
Mark
Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone : Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above
(
- Contribution to journal › Article